Yearly Archives: 2023

SciTech Development Announces First Patient Dosed in Phase 1 Clinical Trial of ST-001

SciTech Development Announces First Patient Dosed in Phase 1 Clinical Trial of ST-001This study is designed to evaluate ST-001 for the treatment of T-cell non-Hodgkin’s lymphoma (NHL). NEWS PROVIDED BY SciTech Development, LLC 20 Dec, 2023, 08:00 ET GROSSE POINTE, Mich., Dec. 20, 2023 /PRNewswire/ — SciTech Development (“SciTech” or the “Company”), a clinical-stage pharmaceutical…

Learn about the Promise of ST-001 from Medical Experts – Catch the SciTech Roundtable Replay Here

Learn about the Promise of ST-001 from Medical Experts – Catch the SciTech Roundtable Replay Here CONTACT David Schaffer

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists NEWS PROVIDED BY SciTech Development, LLC 26 Oct, 2023, 10:00 ET GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ — SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion…

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide NEWS PROVIDED BY SciTech Development, LLC 03 Oct, 2023, 17:19 ET GROSSE POINTE FARMS, Mich., Oct. 3, 2023 /PRNewswire/ –.SciTech announced today that it has successfully manufactured the clinical supply of its lead drug candidate, ST-001 nanoFenretinide, to initiate its upcoming clinical trial in T-cell…

SciTech Development Announces IRB Approval for Human Clinical Trials

SciTech Development Announces IRB Approval for Human Clinical TrialsLead cancer drug candidate, ST-001 nanoFenretinide, has received Institutional Review Board (“IRB”) approval for its upcoming clinical trials for T-Cell Lymphomas. NEWS PROVIDED BY SciTech Development, LLC September 14, 2023 GROSSE POINTE FARMS, Mich., September 14, 2023 (Newswire.com) – SciTech Development (“SciTech” or the “Company”), a clinical-stage…

SciTech Development Raises $2.73 Million in Oversubscribed Financing Round to Advance Clinical Trials for Cancer Treatment

SciTech Development Raises $2.73 Million in Oversubscribed Financing Round to Advance Clinical Trials for Cancer Treatment NEWS PROVIDED BY SciTech Development, LLC 07 Jun, 2023, 14:54 ET — Financing Provides for the Advancement of Clinical Trials – GROSSE POINTE FARMS, Mich., June 7, 2023 /PRNewswire/ — SciTech Development today announced it has closed a $2.73M…